24/7 Patient Assistance: 760-405-8205

Anne Tsao, MD

Medical Oncologist

Write a review
Doctor's profile photo

Request a call back

Conditions Treated Laryngeal Cancer Lung Cancer Pleural Mesothelioma Pleuritis

  • Bio & Insurance Information

    Dr. Tsao was a medical student at the University of Chicago Pritzker School of Medicine and studied as an intern and resident at the University of Indiana. With two board certifications in medical oncology and internal medicine, Dr. Anne Tsao is the director of the mesothelioma and thoracic chemo-radiation programs at University of Texas M.D. Anderson Cancer Center. Her specialty is mesothelioma and this has led her to conduct studies, clinical trials and a lot of research into producing and improving modern mesothelioma treatment methods. Dr. Anne Tsao has also occupied the position of Thoracic, Head and Neck Medical Oncology professor.


  • Education & Training

    dept_icon

    University of Chicago Pritzker School of Medicine - 1998

    Medical School

    dept_icon

    University of Indiana

    Internship

    dept_icon

    Indiana University and University of Texas

    Residency

    dept_icon

    University of Texas

    Fellowship

  • Board Certifications

    American Board of Internal Medicine - Oncology

  • Hospital & Practice

    University of Texas MD Anderson Cancer Center

    Languages: English/Spanish

    713-792-2121

    1515 Holcombe Blvd

    Houston, Texas 77030

    Read More
  • Publications & Memberships

    Dr. Anne Tsao has contributed to 5 publications.

    The Battle Trial: Personalizing Therapy for Lung Cancer.

    Linda Garland, , Raja Flores, Anne Tsao

    See more >>

    Meta-anlysis of the impact of human papilomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC).

    Dayyani F1, Etzel CJ, Liu M, Ho CH, Lippman SM, Tsao AS.

    See more >>

    Individualizing mesothelioma treatment: small steps into a brighter future.

    Garland L, Flores R, Tsao A.

    See more >>

    VeriStrat classifier for survival and time to progression in non-small cell lung cancer (NSCLC) patients treated with erlotinib and b

    Carbone DP, Salmon JS, Billheimer D, Chen H, Sandler A, Roder H, Roder J, Tsypin M, Herbst RS, Tsao AS, Tran HT, Dang TP.

    See more >>

    Phase II randomized, placebo-controlled trial of green tea extract in patients with high-risk oral premalignant lesions.

    Tsao AS1, Liu D, Martin J, Tang XM, Lee JJ, El-Naggar AK, Wistuba I, Culotta KS, Mao L, Gillenwater A, Sagesaka YM, Hong WK, Papadimitrakopoulou V.

    See more >>

    Memberships

    American Radium Society

    American Society of Clinical Oncology

    Southwestern Oncology Group

Verified Patient Reviews

Rate This Doctor

June 26, 2012

by Nicholas G.

Wait Time

Staff

Helpfulness

Knowledge

“Dr. Tsao definitely has a gift! She sits and listens to us and answers all of our questions. She makes sure that we understand what is going on every time we pay her a visit. Thank you very much Dr. Tsao”

January 04, 2010

by Sherrie Moore

Wait Time

Staff

Helpfulness

Knowledge

“There are not enough words to describe Dr. Tsao. She is a doctor that really cares about her patients. Without the help of Dr. Tsao and those at MD Anderson cancer center I would probably not be here today. My chancer where little at my hometown hospital. Thank God for this wonderful doctor!”